Revere Pharmaceuticals reverepharma.com


Revere Pharmaceuticals specializes in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers. R-ketorolac, the company's lead candidate, is a Rac1 inhibitor that shows both clinical and non-clinical evidence of efficacy in ovarian cancer.

Revere Pharmaceuticals specializes in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers. R-ketorolac, the company's lead candidate, is a Rac1 inhibitor that shows both clinical...Show all

Company (Alive / Active)

Phone:

Fax:

36 Orvis Road

Arlington, 02474
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Revere Pharmaceuticals $1.2M Jun 21, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Revere Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)